Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Clinical trial NCT01294735 · COMPLETED

Trial details

NCT number: NCT01294735
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrence of Solid Tumor Glioblastoma Multiforme Melanoma

Start date: 2011-02-01
Primary completion: 2012-04-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.